Ticker > Company >

Niva Bupa Health Ins share price

Niva Bupa Health Insurance Company Ltd.

  49.45 K   58   20 NSE: NIVABUPA BSE: 544286 SECTOR: Insurance

83.74
+1.06 (1.28%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 84.19

Today's Low

₹ 82.24

52 Week High

₹ 91.39

52 Week Low

₹ 67.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

15485.48 Cr.

Enterprise Value

15576.82 Cr.

No. of Shares

184.92 Cr.

P/E

43.01

P/B

4.04

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  20.74

CASH

158.66 Cr.

DEBT

250 Cr.

Promoter Holding

55.3 %

EPS (TTM)

₹  1.95

Sales Growth

0

ROE

4.17 %

ROCE

3.75%

Profit Growth

-38.75 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-133.45%
3 YearNA
5 YearNA

Profit Growth

1 Year-38.75%
3 Year118.48%
5 Year35.86%

ROE%

1 Year4.17%
3 Year6.07%
5 Year-3.23%

ROCE %

1 Year3.75%
3 Year5.4%
5 Year-2.38%

PEG Ratio

NA

Price to Cash Flow

17.11

PAT Margin (%)

2.1554

EPS Growth(%)

NA

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 55.30 0.00
Mar 2026 55.36 0.00
Dec 2025 55.36 0.00
Sep 2025 55.41 0.00
Jun 2025 55.43 0.00
Investors List
* Figures given above are % of equity capital

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue From Operation 1768.61 1422.05 1453.57 1971.95 2273.72
Total Expenditure 1824.92 1627.24 1705.24 1773.33 2278.79
Other Income 163.32 169.92 164.03 142.54 198.04
Interest 9.09 0 0 0 9.23
Depreciation 0 0 0 0 0
Profit Before Tax 97.92 -35.27 -87.64 341.16 183.74
Tax 26.48 0 0 -3.97 45.94
Net Profit 71.44 -35.27 -87.64 345.13 137.8
Adjusted EPS (Rs) 0.39 -0.19 -0.47 1.87 0.75

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Revenue From Operation 45.08 350.94 188.03 180.04 -60.22
Income From Investments 37.54 55.96 137.54 192.47 222.36
Other Income 7.19 6.16 3.15 12.97 0.69
Expenses 284.15 399.5 245.06 171.33 35.79
Provision -19.98 0 0 0 0
Profit Before Tax -196.53 12.54 81.85 213.52 126.81
Tax 0 0 0 0 -3.97
Net Profit -196.53 12.54 81.85 213.52 130.78
Adjusted EPS (Rs) -1.4 0.08 0.48 1.17 0.71

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Sources of funds
Share Capital 1408.6 1510.68 1699.54 1827.03 1847.46
Reserve and Surplus -901.25 -679.97 349.72 1231.16 1365.72
Fair Value A/C -2 -3.36 0.83 -3.75 -20.33
Borrowings 0 0 0 0 0
Policy Holders Fund 250.3 250.73 250.56 253.33 259.07
Funds For Appropriations 0 0 0 0 0
Total Liabilities 755.65 1078.08 2300.65 3307.77 3451.92
Application of funds
Investment 2401.32 3366.09 5458.23 8175.08 9669.65
Loans 0 0 0 0 0
Total Net block 49.16 51.85 58.3 65.9 84.63
Other N/C Assets 0.52 3.73 0.51 9.35 37.79
Net Current Assets -1695.34 -2343.6 -3216.39 -4942.56 -6340.15
Total Assets 755.65 1078.08 2300.65 3307.77 3451.92
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
promoters 55.43 55.41 55.36 55.36 55.30
bupa singapore holdings p... 55.43 55.41 55.36 55.36 55.30
PARTICULARS Jun 2025% Sep 2025% Dec 2025% Mar 2026% Jun 2026%
investors 44.57 44.59 44.64 44.64 44.70
a91 emerging fund ii llp 2.12 2.11 2.11 2.11 2.11
amansa holdings private l... 2.29 2.29 2.29 2.29 2.29
axis mutual fund through ... - - - - 1.47
dsp mutual fund through v... - - 3.67 3.21 1.57
fettle tone llp 7.92 7.92 7.91 7.91 7.18
india business excellence... 2.62 2.62 2.62 2.62 2.62
m pallonji and co pvt ltd... 1.15 1.15 1.15 1.15 1.18
nippon india mutual fund ... - - 1.72 2.52 3.11
sbi mutual fund through v... - - 1.39 1.39 1.39
tata mutual fund through ... - - 1.42 1.49 1.52
v-sciences investments pt... 2.42 2.42 2.42 2.42 2.42
zulia investments pte. lt... 2.05 2.05 2.05 2.04 2.04
dsp flexi cap fund 3.58 3.67 - - -
sbi elss tax saver fund - 1.39 - - -
tata multi asset allocati... - 1.54 - - -
morgan stanley investment... 1.00 - - - -
sbi life insurance co. lt... 1.10 - - - -
sbi long term equity fund... 1.38 - - - -
tata multi asset opportun... 1.40 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2026
Annual Report 2025
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY26
Concall Q4FY25
Concall Q2FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY25

Company News

Niva Bupa Health Insurance Company informs about appointment of chairperson 11 Aug, 12:11 PM Niva Bupa Health Ins - Quaterly Results 31 Jul, 12:00 AM Niva Bupa Health Insurance gets nod to raise Rs 500 crore via NCDs 30 Jul, 4:45 PM Niva Bupa Health Ins - Quaterly Results 9 May, 12:00 AM Niva Bupa Health Insurance Company informs about trading window closure 30 Mar, 5:31 PM Niva Bupa Health Insurance Company informs about newspaper publication 2 Feb, 3:19 PM Niva Bupa Health Ins - Quaterly Results 30 Jan, 12:00 AM Niva Bupa Health Insurance Company informs about allotment of equity shares 14 Nov, 11:14 AM Niva Bupa Health Ins - Quaterly Results 4 Nov, 12:00 AM Niva Bupa Health Ins - Quaterly Results 31 Jul, 5:45 PM Niva Bupa Health Ins - Quaterly Results 31 Jul, 5:45 PM Niva Bupa Health Ins - Quaterly Results 31 Jul, 5:45 PM Niva Bupa Health Insurance Company informs about disclosure 5 Jun, 1:11 PM Niva Bupa Health Insurance Company submits earnings call 8 May, 9:36 AM Niva Bupa Health Ins - Quaterly Results 7 May, 6:46 PM Niva Bupa Health Ins - Quaterly Results 7 May, 6:46 PM Niva Bupa Health Ins - Quaterly Results 7 May, 6:46 PM Niva Bupa Health Insurance Company informs about updates 21 Feb, 5:09 PM Niva Bupa Health Ins - Quaterly Results 4 Feb, 5:13 PM Niva Bupa Health Ins - Quaterly Results 4 Feb, 5:13 PM Niva Bupa Health Ins - Quaterly Results 4 Feb, 5:13 PM Niva Bupa Health Insurance Company informs about completion of tenure of an independent director 20 Jan, 12:14 PM Niva Bupa Health Insurance Company informs about compliance certificate 13 Jan, 5:24 PM Niva Bupa Health Insurance Company informs about change in management 14 Dec, 10:32 AM Niva Bupa Health Ins - Quaterly Results 25 Nov, 2:48 PM Niva Bupa Health Ins - Quaterly Results 25 Nov, 2:48 PM Niva Bupa Health Ins - Quaterly Results 25 Nov, 2:48 PM Niva Bupa Health Insurance Company coming with IPO to raise upto Rs 2326 crore 6 Nov, 3:24 PM Niva Bupa Health Insurance gets SEBI's nod to float IPO 22 Oct, 12:31 PM

Niva Bupa Health Ins Stock Price Analysis and Quick Research Report. Is Niva Bupa Health Ins an attractive stock to invest in?

 

The insurance industry of India consists of 57 insurance companies. Life insurance companies contribute about 42% and approximately 58% are coming from non-life (general) insurance companies. The insurance industry plays an important role in any country’s economic development. Growth in the insurance industry also increases the risk-taking capacity of the country as more individuals are covered for unforeseen events.

Post Liberation, the insurance sector has recorded significant growth. In the past year, the life insurance industry saw greater growth than it has seen in several decades. Increasing awareness, innovative products, and more distribution channels will create robust demand in the industry. Therefore, the future looks promising for the insurance industry.

Life and Health Insurance covers against loss of life whereas property & casualty insurance covers specific assets against losses.

Niva Bupa Health Ins stock price today is Rs 83.74. Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Niva Bupa Health Ins has a PE ratio of 43.0119677435924 which is high and comparatively overvalued .

  • Share Price: - The current share price of Niva Bupa Health Ins is Rs 83.74. One can use valuation calculators of ticker to know if Niva Bupa Health Ins share price is undervalued or overvalued.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Niva Bupa Health Ins is Rs 0 and the yield is 0 %.

Last Updated on:
Brief about Niva Bupa Health Ins

Niva Bupa Health Insurance Company: Business Overview & Financial Analysis

Niva Bupa Health Insurance Company is a leading standalone health insurer (SAHI) in India, headquartered in New Delhi. Jointly promoted by Bupa Singapore Holdings Pte. Ltd. and Fettle Tone LLP (an affiliate of True North), Niva Bupa provides comprehensive health insurance products to retail individuals, families, and corporate groups. Operating across an extensive distribution network of bank partners, agency channels, digital platforms, and corporate brokers, Niva Bupa offers health indemnity, critical illness, personal accident, travel insurance, and wellness-integrated covers across urban, semi-urban, and tier-2/3 Indian markets.

Product Portfolio & Gross Direct Written Premium Mix of Niva Bupa (FY26)

Niva Bupa structures its health insurance underwriting across retail health, group health, and travel insurance lines.

  • Retail Health Insurance Share – 68.5% of Total GDPI
  • Group Health Insurance Share – 29.2% of Total GDPI
  • Personal Accident & Travel Insurance Share – 2.3% of Total GDPI
  • Total Gross Direct Written Premium (GDPI - FY26) – Rs 6,850.40 crore (+22.5% YoY)

The Retail Health insurance vertical serves as the core margin driver, delivering high underwriting retention and strong customer renewal rates. Group health covers provide volume scale across corporate enterprise accounts and employee benefit programs.

Market Share & Industry Position of Niva Bupa (Q4 FY26 / FY26)

Niva Bupa tracks market share metrics among standalone health insurers and the overall Indian non-life insurance industry.

  • Standalone Health Insurers (SAHI) Market Share – ~17.2% Market Share Position
  • Overall Non-Life Insurance Industry Market Share – ~2.4% Market Share Position
  • Overall Health Insurance Market Share – ~8.5% Market Share Position
  • Total Active Lives Covered – 14.5+ million insured lives

The company holds a strong market position among standalone health insurance providers in India, backed by its flagship 'ReAssure' and 'Health Companion' product series. Active insured lives crossed 14.5 million across retail and group schemes during FY26.

Distribution Channel Mix & Partner Network of Niva Bupa (FY26)

Niva Bupa distributes its health policies through a multi-channel architecture including bancassurance, agency networks, and digital platforms.

  • Bancassurance & Institutional Partners Share – 38.5% of Total GDPI
  • Direct Agency & Tied Agents Channel Share – 32.0% of Total GDPI
  • Digital & Direct-to-Consumer (D2C) Channels Share – 16.5% of Total GDPI
  • Corporate Brokers & Institutional Agents Share – 13.0% of Total GDPI
  • Total Individual Tied Agency Agents – 142,000+ active agents
  • Active Bancassurance Partner Branches – 35,000+ bank branch touchpoints (HDFC Bank, Axis Bank, Indian Bank, Punjab National Bank)

Bancassurance partnerships with leading nationalized and private banks supply nearly four-fifths of institutional distribution leads. The direct agency network of over 142,000 tied agents drives deep penetration across Tier-2 and Tier-3 regional markets.

Key Insurance KPIs & Underwriting Metrics of Niva Bupa (Q4 FY26 / FY26)

Niva Bupa tracks claim settlement ratios, net combined ratios, persistency rates, and solvency buffers across financial cycles.

  • Incurred Claim Ratio (Net Claim Ratio - FY26) – 64.5% (vs 66.2% in FY25)
  • Net Combined Ratio (FY26) – 98.2% (underwriting profitability threshold achieved)
  • Solvency Ratio (Q4 FY26) – 2.25x (vs RBI/IRDAI mandatory minimum threshold of 1.50x)
  • 13th Month Persistency Rate – 78.5%
  • 61st Month Persistency Rate – 54.2%
  • Claim Settlement Ratio – 92.8% within 30 days

Underwriting profitability improved in FY26 as the net combined ratio compressed to 98.2%, driven by disciplined health claims management and scale efficiencies. Solvency buffers held strong at 2.25x, providing adequate headroom above regulatory capital mandates.

Hospital Network & Cashless Claims Footprint of Niva Bupa (FY26)

Niva Bupa maintains a cashless healthcare network spanning private hospital chains and regional multi-specialty centers across India.

  • Total Empanelled Network Hospitals – 10,500+ healthcare facilities across India
  • Cashless Claim Settlement Volume Share – >84% of total claims processed cashless
  • Auto-Pre-Authorization Processing Time – <30 minutes via digital claims engine
  • Average Claim Settlement Value – Rs 48,500 per claim

Empanelled hospital networks cover over 10,500 healthcare institutions, enabling seamless cashless treatment facilities for policyholders. Automated pre-authorization tools process over four-fifths of routine cashless claims within 30 minutes.

Technology Infrastructure & Digital Adoption Scale of Niva Bupa (FY26)

Niva Bupa deploys digital platforms, mobile applications, and AI-driven underwriting engines to streamline policy issuance.

  • Digital Policy Issuance Share – >96% of fresh policies issued paperless
  • Niva Bupa Health App Registered Users – 3.8 million active downloads
  • Automated Underwriting Approval Share – >72% of retail policies underwritten digitally
  • Digital Renewal Premium Collection Share – 62.0% of total renewal collections

Digital channels process over 96% of new retail health policy issuances without manual paperwork intervention. The proprietary Niva Bupa mobile application facilitates instant policy renewals, claim status tracking, and wellness reward redemptions.

Latest Quarterly Financial Performance of Niva Bupa (Q4 FY26)

Niva Bupa recorded top-line premium expansion and net underwriting profit during the fourth quarter of FY26.

  • Gross Direct Written Premium (GDPI) – Rs 1,885.40 crore (+24.2% YoY)
  • Net Written Premium (NWP) – Rs 1,420.50 crore (+22.8% YoY)
  • Consolidated Operating Profit / Underwriting Surplus – Rs 118.50 crore (+28.5% YoY)
  • Consolidated Net Profit After Tax (PAT) – Rs 88.20 crore (+34.2% YoY)
  • Solvency Margin Surplus – 2.25x

Fourth-quarter gross premium income expanded 24.2% year-on-year to Rs 1,885.40 crore, supported by retail renewal momentum and bancassurance sourcing. Consolidated Net Profit After Tax reached Rs 88.20 crore, while underwriting surplus widened across core retail lines.

Consolidated Annual Financial Performance of Niva Bupa (FY26)

Niva Bupa achieved record gross premium growth and full-year net profitability expansion for full financial year FY26.

  • Full Year Gross Direct Written Premium (GDPI) – Rs 6,850.40 crore (+22.5% YoY)
  • Full Year Net Earned Premium (NEP) – Rs 4,980.20 crore (+21.8% YoY)
  • Full Year Investment Income & Capital Gains – Rs 485.20 crore (+18.5% YoY)
  • Consolidated Net Profit After Tax (PAT) – Rs 285.40 crore (+42.5% YoY)
  • Return on Equity (ROE) – 14.8%

Full-year gross premium income crossed Rs 6,850 crore in FY26, as consolidated Net Profit After Tax expanded 42.5% to Rs 285.40 crore. Operational execution was supported by retail volume growth, improved claim settlement ratios, and investment portfolio yields.

Investment Portfolio & Capital Structure Metrics of Niva Bupa (Q4 FY26)

Niva Bupa manages a high-quality investment portfolio comprising sovereign debt, corporate bonds, and liquid instruments.

  • Total Assets Under Management (AUM) – Rs 6,250.00 crore (+20.5% YoY)
  • Sovereign & High-Grade Corporate Debt Share – >92% of total AUM (AAA/AA rated)
  • Investment Yield (Annualised) – 7.42%
  • Net Worth Base – Rs 2,150.00 crore
  • Debt to Equity Ratio – Zero Debt (0.00x)

Total Assets Under Management expanded to Rs 6,250.00 crore, generating an annualised investment yield of 7.42%. Over 92% of the investment portfolio is allocated toward sovereign paper and AAA-rated corporate bonds to preserve capital security.

Strategic Outlook & Management Commentary of Niva Bupa (Q4 FY26 / FY27)

Management guidance outlines strategic priorities centered on retail market share expansion, bancassurance deepening, and combined ratio optimization.

  • Management targets achieving a 20%–22% GDPI CAGR over the FY27–FY29 period, outperforming industry growth.
  • Net Combined Ratio is guided to sustain within the 96.0%–98.0% corridor through disciplined claims underwriting.
  • Direct Agency network will add 25,000+ new tied agents annually across Tier-2 and Tier-3 markets.
  • Bancassurance penetration will be deepened across regional rural bank branches and partner networks.
  • Digital AI integration will focus on real-time claims fraud detection and automated wellness rewards tracking.

Management anticipates rising health awareness and medical inflation to drive retail health policy adoption across domestic consumer segments. Operational focus centers on scaling tied agency coverage, deepening hospital network integrations, and maintaining strong solvency buffers.

Want to filter out stocks using your own financial benchmarks? You can use the Stock Screener on Finology Ticker to identify and compare companies based on specific growth and efficiency metrics.

Sources & References

  1. Niva Bupa Health Insurance Company Q4 & Full Year FY26 Consolidated Financial Disclosures (May 2026)
  2. Niva Bupa Health Insurance Company Regulatory Disclosures under IRDAI Reporting Formats (May 2026)
  3. BSE India & National Stock Exchange of India (NSE) Corporate Filings for Niva Bupa Health Insurance Company
  4. Ticker Finology Niva Bupa Page

Disclaimer
The information presented above on Niva Bupa Health Insurance Company has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Niva Bupa Health Insurance Company page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Read More
X